215 related articles for article (PubMed ID: 34164563)
1. Radiogenomics in brain, breast, and lung cancer: opportunities and challenges.
Singh A; Chitalia R; Kontos D
J Med Imaging (Bellingham); 2021 May; 8(3):031907. PubMed ID: 34164563
[TBL] [Abstract][Full Text] [Related]
2. Combining molecular and imaging metrics in cancer: radiogenomics.
Lo Gullo R; Daimiel I; Morris EA; Pinker K
Insights Imaging; 2020 Jan; 11(1):1. PubMed ID: 31901171
[TBL] [Abstract][Full Text] [Related]
3. The Impact of Normalization Approaches to Automatically Detect Radiogenomic Phenotypes Characterizing Breast Cancer Receptors Status.
Castaldo R; Pane K; Nicolai E; Salvatore M; Franzese M
Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32102334
[TBL] [Abstract][Full Text] [Related]
4. Impact of radiogenomics in esophageal cancer on clinical outcomes: A pilot study.
Brancato V; Garbino N; Mannelli L; Aiello M; Salvatore M; Franzese M; Cavaliere C
World J Gastroenterol; 2021 Sep; 27(36):6110-6127. PubMed ID: 34629823
[TBL] [Abstract][Full Text] [Related]
5. Integrative radiogenomics for virtual biopsy and treatment monitoring in ovarian cancer.
Martin-Gonzalez P; Crispin-Ortuzar M; Rundo L; Delgado-Ortet M; Reinius M; Beer L; Woitek R; Ursprung S; Addley H; Brenton JD; Markowetz F; Sala E
Insights Imaging; 2020 Aug; 11(1):94. PubMed ID: 32804260
[TBL] [Abstract][Full Text] [Related]
6. Radiogenomic Signatures of Oncotype DX Recurrence Score Enable Prediction of Survival in Estrogen Receptor-Positive Breast Cancer: A Multicohort Study.
Fan M; Cui Y; You C; Liu L; Gu Y; Peng W; Bai Q; Gao X; Li L
Radiology; 2022 Mar; 302(3):516-524. PubMed ID: 34846204
[TBL] [Abstract][Full Text] [Related]
7. Personalized management of prostate cancer: from molecular and imaging markers to radiogenomics.
Mytsyk Y; Borzhiyevs'kyy A; Kobilnyk Y; Shulyak AV; Dutka I; Borzhiyevs'kyy O; Górecki A
Pol J Radiol; 2022; 87():e58-e62. PubMed ID: 35140829
[TBL] [Abstract][Full Text] [Related]
8. Radiogenomics in personalized management of lung cancer patients: Where are we?
Araujo-Filho JAB; Mayoral M; Horvat N; Santini FC; Gibbs P; Ginsberg MS
Clin Imaging; 2022 Apr; 84():54-60. PubMed ID: 35144039
[TBL] [Abstract][Full Text] [Related]
9. Opportunities and Advances in Radiomics and Radiogenomics for Pediatric Medulloblastoma Tumors.
Ismail M; Craig S; Ahmed R; de Blank P; Tiwari P
Diagnostics (Basel); 2023 Aug; 13(17):. PubMed ID: 37685265
[TBL] [Abstract][Full Text] [Related]
10. Radiomics and radiogenomics for precision radiotherapy.
Wu J; Tha KK; Xing L; Li R
J Radiat Res; 2018 Mar; 59(suppl_1):i25-i31. PubMed ID: 29385618
[TBL] [Abstract][Full Text] [Related]
11. Data-Driven Radiogenomic Approach for Deciphering Molecular Mechanisms Underlying Imaging Phenotypes in Lung Adenocarcinoma: A Pilot Study.
Fischer S; Spath N; Hamed M
Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902378
[TBL] [Abstract][Full Text] [Related]
12. Contrast-Enhanced Computed Tomography-Based Radiogenomics Analysis for Predicting Prognosis in Gastric Cancer.
Liu H; Wang Y; Liu Y; Lin D; Zhang C; Zhao Y; Chen L; Li Y; Yuan J; Chen Z; Yu J; Kong W; Chen T
Front Oncol; 2022; 12():882786. PubMed ID: 35814414
[TBL] [Abstract][Full Text] [Related]
13. Radiogenomics: a key component of precision cancer medicine.
Liu Z; Duan T; Zhang Y; Weng S; Xu H; Ren Y; Zhang Z; Han X
Br J Cancer; 2023 Sep; 129(5):741-753. PubMed ID: 37414827
[TBL] [Abstract][Full Text] [Related]
14. The Era of Radiogenomics in Precision Medicine: An Emerging Approach to Support Diagnosis, Treatment Decisions, and Prognostication in Oncology.
Shui L; Ren H; Yang X; Li J; Chen Z; Yi C; Zhu H; Shui P
Front Oncol; 2020; 10():570465. PubMed ID: 33575207
[TBL] [Abstract][Full Text] [Related]
15. Radiogenomics of breast cancer using dynamic contrast enhanced MRI and gene expression profiling.
Yeh AC; Li H; Zhu Y; Zhang J; Khramtsova G; Drukker K; Edwards A; McGregor S; Yoshimatsu T; Zheng Y; Niu Q; Abe H; Mueller J; Conzen S; Ji Y; Giger ML; Olopade OI
Cancer Imaging; 2019 Jul; 19(1):48. PubMed ID: 31307537
[TBL] [Abstract][Full Text] [Related]
16. Radiomics and Radiogenomics in Preclinical Imaging on Murine Models: A Narrative Review.
Monti S; Truppa ME; Albanese S; Mancini M
J Pers Med; 2023 Jul; 13(8):. PubMed ID: 37623455
[TBL] [Abstract][Full Text] [Related]
17. Radiogenomics of lower-grade gliomas: a radiomic signature as a biological surrogate for survival prediction.
Qian Z; Li Y; Sun Z; Fan X; Xu K; Wang K; Li S; Zhang Z; Jiang T; Liu X; Wang Y
Aging (Albany NY); 2018 Oct; 10(10):2884-2899. PubMed ID: 30362964
[TBL] [Abstract][Full Text] [Related]
18. A Coclinical Radiogenomic Validation Study: Conserved Magnetic Resonance Radiomic Appearance of Periostin-Expressing Glioblastoma in Patients and Xenograft Models.
Zinn PO; Singh SK; Kotrotsou A; Hassan I; Thomas G; Luedi MM; Elakkad A; Elshafeey N; Idris T; Mosley J; Gumin J; Fuller GN; de Groot JF; Baladandayuthapani V; Sulman EP; Kumar AJ; Sawaya R; Lang FF; Piwnica-Worms D; Colen RR
Clin Cancer Res; 2018 Dec; 24(24):6288-6299. PubMed ID: 30054278
[TBL] [Abstract][Full Text] [Related]
19. Radiogenomics model for overall survival prediction of glioblastoma.
Wijethilake N; Islam M; Ren H
Med Biol Eng Comput; 2020 Aug; 58(8):1767-1777. PubMed ID: 32488372
[TBL] [Abstract][Full Text] [Related]
20. Breast MRI radiogenomics: Current status and research implications.
Grimm LJ
J Magn Reson Imaging; 2016 Jun; 43(6):1269-78. PubMed ID: 26663695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
